Mary Jo Turk, PhD, has been named the O. Ross McIntyre, MD, Professor at the Geisel School of Medicine at Dartmouth. Turk, a professor of microbiology and immunology and co-director of the Immunology and Cancer Immunotherapy Program at Dartmouth’s Norris Cotton Cancer Center, joined the faculty of Dartmouth’s medical school 15 years ago and conducts pioneering research on the complex interactions between the immune system and cancer.
Findings from an innovative new study led by researchers at Dartmouth’s Geisel School of Medicine and published this week in Nature Microbiology reveal that the way in which human fungal pathogens form colonies can significantly impact their ability to cause disease.
Findings from a Dartmouth-led study published in the journal Science Translational Medicine, are offering new insights into neonatal herpes, its impact on developing nervous systems, and how newborns can be protected from the disease. In this innovative study, investigators were able to measure not only mortality but also neurological consequences of infection in mice who acquired the virus.
Michael Gleeson MD-PhD ’10, once disabled by reactive arthritis, regained his health with the right medical care and the help of his wife, Kirsten. His experience inspired him to become a physician-researcher.
With funding from the Falk Foundation, Mike Whitfield’s lab is mapping which genes interact with each other in the debilitating disease scleroderma. Their discoveries reveal new avenues for treatment.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, report researchers from Dartmouth and Case Western Reserve University.
Geisel MD-PhD candidate Yike Jiang received the Priscilla Schaffer Award for Outstanding Graduate Student Presentation during the 40th annual International Herpesvirus Workshop, which brings together more than 600 investigators from around the world.
The Guardian – This article mentions Dartmouth’s Geisel School of Medicine in an article about the overall impact of a cancer immunotherapy clinical trial on melanoma patients, and that the two drugs used in the trial, ipilimumab and nivolumab, were created by the biotech firm called Medarex founded by immunologists from Geisel.
Dartmouth researchers are among 37 principal investigators and their dedicated trainees to receive the American Association of Immunologists inaugural Careers in Immunology Fellowship award.
An article published in the journal Science provides support for a new—and still controversial—understanding of the immune system.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.